Alcon Goodwill and Intangible Assets 2019-2024 | ALC
Alcon goodwill and intangible assets from 2019 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Alcon goodwill and intangible assets for the quarter ending September 30, 2024 were $17.656B, a 2.65% decline year-over-year.
- Alcon goodwill and intangible assets for 2023 were $17.986B, a 3.38% decline from 2022.
- Alcon goodwill and intangible assets for 2022 were $18.615B, a 5.35% increase from 2021.
- Alcon goodwill and intangible assets for 2021 were $17.67B, a 1.84% decline from 2020.
| Alcon Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023 | $17,986 |
| 2022 | $18,615 |
| 2021 | $17,670 |
| 2020 | $18,002 |
| 2019 | $19,136 |
| 2018 | $19,578 |
| Alcon Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $17,656 |
| 2024-06-30 | $17,686 |
| 2024-03-31 | $17,848 |
| 2023-12-31 | $17,986 |
| 2023-09-30 | $18,137 |
| 2023-06-30 | $18,338 |
| 2023-03-31 | $18,493 |
| 2022-12-31 | $18,615 |
| 2022-09-30 | $17,640 |
| 2022-06-30 | $17,716 |
| 2022-03-31 | $17,919 |
| 2021-12-31 | $17,670 |
| 2021-09-30 | $17,802 |
| 2021-06-30 | $18,091 |
| 2021-03-31 | $17,832 |
| 2020-12-31 | $18,002 |
| 2020-09-30 | $18,291 |
| 2020-06-30 | $18,595 |
| 2020-03-31 | $18,867 |
| 2019-12-31 | $19,136 |
| 2019-09-30 | $19,385 |
| 2019-06-30 | $19,624 |
| 2019-03-31 | $0 |
| 2018-12-31 | |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.521B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.634B | 24.11 |
| Intuitive Surgical (ISRG) | United States | $186.606B | 97.56 |
| Edwards Lifesciences (EW) | United States | $43.604B | 27.69 |
| IQVIA Holdings (IQV) | United States | $34.761B | 19.15 |
| IDEXX Laboratories (IDXX) | United States | $33.493B | 39.44 |
| DexCom (DXCM) | United States | $29.615B | 44.60 |
| Waters (WAT) | United States | $21.413B | 31.66 |
| STERIS (STE) | Ireland | $20.170B | 23.22 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.359B | 0.00 |
| Hologic (HOLX) | United States | $16.058B | 17.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.192B | 13.54 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Globus Medical (GMED) | United States | $11.158B | 28.25 |
| Penumbra (PEN) | United States | $9.346B | 91.55 |
| Masimo (MASI) | United States | $9.102B | 44.04 |
| Teleflex (TFX) | United States | $8.118B | 12.95 |
| Glaukos (GKOS) | United States | $7.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.457B | 25.26 |
| PROCEPT BioRobotics (PRCT) | United States | $4.215B | 0.00 |
| Inari Medical (NARI) | United States | $3.185B | 0.00 |
| Veracyte (VCYT) | United States | $3.028B | 90.86 |
| Nihon Kohden (NHNKY) | Japan | $2.590B | 19.67 |
| LivaNova (LIVN) | United Kingdom | $2.579B | 14.89 |
| Tandem Diabetes Care (TNDM) | United States | $2.185B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.096B | 18.84 |
| TransMedics (TMDX) | United States | $2.031B | 64.39 |
| Integra LifeSciences Holdings (IART) | United States | $1.675B | 8.75 |
| RxSight (RXST) | United States | $1.539B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.255B | 0.00 |
| Artivion (AORT) | United States | $1.173B | 77.69 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Paragon 28 (FNA) | United States | $0.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.760B | 12.92 |
| Mesa Laboratories (MLAB) | United States | $0.714B | 16.83 |
| IRadimed (IRMD) | United States | $0.676B | 36.54 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.657B | 0.00 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.568B | 29.92 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.407B | 22.01 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.357B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.171B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| Nevro (NVRO) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.123B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.118B | 12.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| 908 Devices (MASS) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |